Market Overview

Integra LifeSciences Receives FDA Clearance for Expanded Indication for Spinal Device

Related IART
UPDATE: Integra LifeSciences Announces FDA Clearance And Controlled Market Release Of Expandable Interbody System For Spinal Surgery
Integra LifeSciences Introduces Integra Pocket Strip And Integra Shaped Strip DBM Implants
EMCORE Selling Space Solar Business to Veritas Capital (Fox Business)

Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that the Food and Drug Administration (FDA) has approved an expanded indication for use of the Integra® Vu aPOD™ Prime Intervertebral Body Fusion Device (IBD) in anterior lumbar interbody fusion (ALIF) procedures. The new stand-alone indication includes four points of fixation, which is composed of two screws and a SpinPlate™. The Integra® Vu aPOD™ Prime IBD will be featured at the Congress of Neurological Surgeons (CNS) annual meeting, October 6 – 10, 2012, in Chicago, Illinois.

Posted-In: News FDA

 

Related Articles (IART)

Around the Web, We're Loving...

Get Benzinga's Newsletters